Specialty-Specific Medical Language Model for Immune-Mediated Diseases
Quick Take
A domain-specific Named Entity Recognition model for immune-mediated diseases achieved an F1 score of 0.89, outperforming general-purpose NLP systems. The model, developed with 371 annotated case reports, enhances clinical data extraction and supports tasks like disease monitoring and cohort identification.
Key Points
- Developed a specialized NER model for immunology and infectious diseases.
- Achieved an F1 score of 0.89 using transformer-based architecture.
- Utilized a dataset of 371 manually annotated case reports.
- Outperformed baseline and zero-shot NER systems in evaluations.
- Supports downstream tasks like clinical decision support and disease monitoring.
Article Content
From source RSS / original summaryarXiv:2605. 28838v1 Announce Type: new Abstract: Extracting detailed clinical information from free-text medical narratives remains a practical challenge for researchers and healthcare systems. Terminology for immune-mediated and infectious diseases is especially inconsistent across sources, which often limits the ability of general-purpose Natural Language Processing (NLP) systems to capture the relevant biomedical concepts with sufficient granularity.
We developed a domain-specific Named Entity Recognition (NER) model tailored to identify disease-related entities occurring in immunology and infectious disease contexts. We assembled and manually annotated a dataset of 371 case reports in collaboration with two clinical specialists, defining twelve entity classes covering immune-mediated and infectious conditions as well as related symptoms and clinical descriptors.
We evaluated several modeling strategies, including the MedicalNER architecture with multiple healthcare-specific embeddings, a BERT-based token classification model, and zero-shot NER systems. The strongest performance was obtained with a transformer-based model trained on clinical-domain embeddings, which reached an F1 score of 0. 89, consistently outperforming baseline and zero-shot approaches.
The combination of specialized embeddings and expert annotation proved particularly valuable for capturing nuanced disease terminology and improving generalization across heterogeneous biomedical text. The prompted LLM baseline achieved substantially lower performance under the same evaluation protocol, reflecting difficulties in producing span-consistent outputs for fine-grained entity boundaries despite detailed prompting.
The resulting model provides a structured way to analyze case reports and can support downstream tasks such as cohort identification, disease monitoring, and clinical decision support.
Reader Mode unavailable (could not extract clean content).
Want this in your inbox every morning?
Daily brief at your local 8am — bilingual EN/中文, free.
More from arXiv cs.CL
See more →Time to REFLECT: Can We Trust LLM Judges for Evidence-based Research Agents?
The reliability of LLM judges for evaluating deep research agents is critically assessed using the REFLECT benchmark.